Skip to content
lifestyle.spaziotribu.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Insight Molecular Diagnostics Inc.
IMDx Reports Third Quarter 2026 Results and Provides Corporate Update
November 16, 2026
Insight Molecular Diagnostics Announces Proposed Public Offering
November 16, 2026
iMDx to Release Third Quarter Results on November 16, 2026
November 5, 2026
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
October 14, 2026
iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings
October 12, 2026
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
September 2, 2026
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
August 20, 2026
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
August 20, 2026
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1×1 Conference
August 19, 2026
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
July 23, 2026
1
2
Next Page
→